固定剂量与松散剂量组合抗糖尿病治疗和2型糖尿病的心脏结局:全国性比较有效性研究
Qiaoling Liu1,2, Paul Welsh1, Carlos Celis-Morales1,3,4
1School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
Cardiovascular diabetology
|September 23, 2025
概括
对2型糖尿病的固定剂量组合治疗 (FDC) 显示,心力衰竭的风险降低,特别是在老年人中. 改善的药物坚持显著促进了这种有益的效果.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 组合疗法越来越多地用于2型糖尿病,以更快地达到血糖目标.
- 长期心脏结结果比较固定剂量组合 (FDCs) 和松散剂量组合 (LDCs) 尚未确立.
研究的目的:
- 评估口服抗糖尿病FDC治疗是否与与LDC治疗相比,在2型糖尿病患者中与更好的心脏结局有关.
- 调查药物坚持作为这些协会中介者的作用.
主要方法:
- 一项基于人口的队列研究,使用瑞典国家登记册.
- 倾向性得分匹配用于比较FDC和LDC疗法的新用户.
- 关键结局包括主要的不良心血管事件和减少估计的膜过率 (eGFR <30毫升/分钟/1.73m2).
主要成果:
- 该研究包括一个匹配的队列,平均随访时间为3.8至4.0年.
- 与LDC用户 (46.5%) 相比,FDC用户表现出更高的药物坚持 (68.6%).
- FDC与心力衰竭率降低有关 (HR=0.88),坚持调节了这一效应的47%. 这种益处在65岁及以上的人群中更为明显.
结论:
- 针对2型糖尿病的固定剂量联合治疗与心力衰竭的发病率较低有关,特别是在老年患者中.
- 强化药物坚持是重要的因素,介导了观察到的心脏和脏的好处的很大一部分.
相关概念视频
01:01Dosage Regimen: Fixed Dose
2.3K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.3K
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
209
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
209
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
942
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
942
01:22Heart Failure Drugs: Diuretics
809
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
809
01:11Renal Failure: Dose Adjustments
438
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
438
01:16Insulin: Dosing Regimen and Adverse Effects
689
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
689